CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >
Effect of local complement activation in hepatocytes on the development of Plasmodium in the infrared phase
Received date: 2023-11-01
Revised date: 2023-12-26
Online published: 2024-04-26
Supported by
National Natural Science Foundation of China(81830067);National Natural Science Foundation of China(81802033)
Objective To investigate the effect of hepatocyte local complement on the development of the liver-stage of Plasmodium parasites. Methods Hepa1-6 cells and HepG2-CD81 cells were collected, lysed, and RNA was extracted, respectively. Reverse transcription PCR amplified C3, C3aR1, C5, C5aR1 gene. Hepa1-6 cells and HepG2-CD81 cells suspension were lysed with protease and phosphatase, respectively. The protein concentration was measured using the bicinchoninic acid (BCA) assay and the expression of complement and receptor in hepatocytes was measured using Western blotting. Kunming mice fed with the BY265-RFP strain of P. yoelii expressing red fluorescence and the ANKA strain of P. berghei were fed with Anopheles stephensi for blood sucking. After 17-19 days, anatomically separated salivary glands from An. stephensi mosquitoes and added 50 000 sporozites into 24-well plate containing 105 HepG2-CD81 cells per well for co-incubation, set an additional group that the cells were incubated with C5aR antagonist (40 nnmol/L, 500 μl/well）3 h after co-incubation. Cells were fixed with 4% paraformaldehyde and blocked, the non permeable group was incubated overnight at 4 ℃ with primary C3a rabbit anti human IgG antibody (1∶500) or rC5a rabbit anti human IgG antibody (1∶500), followed by 1 hour of incubation with green Dylight 488 fluorescent labeled goat anti rabbit IgG secondary antibody (1∶400), and 5 minutes of incubation with DAPI staining solution; added a primary antibody UIS4 goat polyclonal antibody (1∶500) to the permeable group and incubated overnight at 4 ℃, then added green IFKineTM fluorescent labeled donkey anti rabbit IgG secondary antibody (1∶400) and incubated for 1 h, added CD88 rabbit polyclonal antibody (1∶400) to incubate overnight at 4 ℃, added the red Dylight 649 fluorescent labeled goat anti rabbit IgG secondary antibody (1∶400) to incubate for 1 h, added DAPI staining solution to incubate for 5 min, and observed the enrichment of complement around parasitophorous vacuoles under laser confocal microscopy. Take cobra venom factor (CVF) and inject it intraperitoneally into C57BL/6 mice as the CVF group; and set up a C3-/- group (C3 whole gene knockout C3-/- mice) and a control group (C57BL/6 mice). The mice in each group were challenged with 10 000 P. yoelii sporozoites. Total RNA was extracted from the liver and reverse transcribed to synthesize cDNA. The content of Plasmodium 18S rRNA was determined by fluorescence quantitative PCR, and the liver parasite burden were indicated as the relative content of 18S rRNA. Ten mice in control group (C57BL/6 mice) and C3aR-/- group were challenged intravenously with 200 P. yoelii sporozoites, respectively, via tail vein. Five mice in control group (C57BL/6 mice), 6 C5aR whole gene knockout C5aR-/- mice and 5 liver C5aR conditional knockout Alb-Cre+/+C5aRflox/flox hybrid mice were challenged with 1 000 P. yoelii sporozoites. Six mice in control group (C57BL/6 mice) and C5aR-/- group were challenged with 1 000 P. berghei sporozoites. Tail vein blood was daily collected 3 d after challenge for making a thin blood smear and observed parasitemia after Giemsa staining, till all mice were founded malaria blood stages. Statistical analysis was conducted using Graphpad Prism 9.0 software. Normal distribution data is compared to continuous variables using t-tests, and pairwise differences are compared using one-way analysis of variance (ANOVA) for multiple comparisons; non normal distribution data are compared using Mann-Whitney U test. Results The PCR results showed that C3 (358 bp), C5 (267 bp) and their receptors C3aR (222 bp) and C5aR (388 bp) genes were amplified in Hepa1-6 cell line; C3 (202 bp), C5 (220 bp), C3aR (299 bp), and C5aR (374 bp) genes were amplified in HepG2-CD81 cell line. Western blotting results showed that both types expressed C3, C5, C3aR, and C5aR proteins. Laser confocal microscopy imaging showed that the cell nucleus showed blue fluorescence after DAPI staining, while the P. yoelii liver stages showed red spontaneous fluorescence. In the non permeable group, the highly expressed C3a and C5a in HepG2-CD81 cells show green fluorescence, overlapping with the distribution of parasitophorous vacuoles. The C5aR (pink) of the transmembrane group overlaps with the membrane of parasitophorous vacuoles (green); C5aR expression is still present on the membrane of parasitophorous vacuoles treated with C5aR antagonists. After infection with P. yoelii sporozoites, the relative content of 18S rRNA in the liver of the control group was 0.954 ± 0.523, the CVF group was 0.958 ± 0.231, and the C3-/- group was 0.638 ± 0.437. There was no statistically significant difference among the three groups (P > 0.05). After infection with P. yoelii sporozoites, the control group and C3aR-/- mice showed the blood stages after (5.30 ± 0.78) d and (5.30 ± 0.78) d, respectively. After infection with P. berghei sporozoites, the control group and C5aR-/- mice showed the blood stages after (3.67 ± 0.47) d and (3.83 ± 0.69) d, respectively. There was no statistically significant difference in the appearance time of the the blood stages between the two groups of mice and the control group mice (P > 0.05). After infection with P. yoelii sporozoites, the appearance time of the blood stages in the control group, Alb-cre+/+C5aRflox/flox mice, and C5aR-/- mice were (4.00 ± 0.00), (4.00 ± 0.00), and (4.17 ± 0.37) d, respectively, with no statistically significant difference (P > 0.05). Conclusion The activation of hepatocyte local complement had no significant effect on the development of Plasmodium liver-stage.
Key words： Plasmodium; Liver stage; hepatocyte local complement
TAN Nie , JIAO Shiming , DING Yan , ZHU Chengyu , XU Wenyue . Effect of local complement activation in hepatocytes on the development of Plasmodium in the infrared phase[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024 , 42(2) : 169 -176 . DOI: 10.12140/j.issn.1000-7423.2024.02.006
| [1] | WHO. World malaria report 2023[R]. Geneva: World Health Organization, 2023: 21, 78, 80. |
| [2] | Noedl H, Se Y, Schaecher K, et al. Evidence of artemisinin-resistant malaria in western Cambodia[J]. N Engl J Med, 2008, 359(24): 2619-2620. |
| [3] | Balikagala B, Fukuda N, Ikeda M, et al. Evidence of artemisinin-resistant malaria in Africa[J]. N Engl J Med, 2021, 385(13): 1163-1171. |
| [4] | Hemingway J, Ranson H. Insecticide resistance in insect vectors of human disease[J]. Annu Rev Entomol, 2000, 45: 371-391. |
| [5] | Zhu GD, Cao J. Regular assessment is an effective approach to maintaining the capacity of prevention of re-establishment from imported malaria in China[J]. Chin J Schisto Control, 2023, 9(2): 113-115, 120. (in Chinese) |
| (朱国鼎, 曹俊. 朝督暮责: 定期开展评估是保持防止疟疾输入再传播能力的有效手段[J]. 中国血吸虫病防治杂志, 2023, 9(2): 113-115, 120.) | |
| [6] | Zhu GD, Gao Q, Cao J. Challenges and countermeasures in prevention of re-establishment of imported malaria in China[J]. Chin J Schisto Control, 2021, 33(1): 7-9, 21. (in Chinese) |
| (朱国鼎, 高琪, 曹俊. 中国防止疟疾输入再传播面临的挑战和应对策略[J]. 中国血吸虫病防治杂志, 2021, 33(1): 7-9, 21.) | |
| [7] | Xu WY. Development and application of the world’s first malaria subunit vaccine RTS, S/AS01[J]. Chin J Schisto Control, 2021, 7(6): 557-559. (in Chinese) |
| (徐文岳. 全球首款疟疾疫苗RTS, S/AS01的研发和应用[J]. 中国血吸虫病防治杂志, 2021, 7(6): 557-559.) | |
| [8] | Stewart MJ, Vanderberg JP. Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility[J]. J Protozool, 1988, 35(3): 389-393. |
| [9] | Mota MM, Pradel G, Vanderberg JP, et al. Migration of Plasmodium sporozoites through cells before infection[J]. Science, 2001, 291(5501): 141-144. |
| [10] | Phillips MA, Burrows JN, Manyando C, et al. Malaria[J]. Nat Rev Dis Primers, 2017, 3: 17050. |
| [11] | Amino R, Giovannini D, Thiberge S, et al. Host cell traversal is important for progression of the malaria parasite through the dermis to the liver[J]. Cell Host Microbe, 2008, 3(2): 88-96. |
| [12] | Amino R, Thiberge S, Blazquez S, et al. Imaging malaria sporozoites in the dermis of the mammalian host[J]. Nat Protoc, 2007, 2(7): 1705-1712. |
| [13] | Amino R, Thiberge S, Martin B, et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal[J]. Nat Med, 2006, 12(2): 220-224. |
| [14] | Gueirard P, Tavares J, Thiberge S, et al. Development of the malaria parasite in the skin of the mammalian host[J]. Proc Natl Acad Sci USA, 2010, 107(43): 18640-18645. |
| [15] | Voza T, Miller JL, Kappe SH, et al. Extrahepatic exoerythrocytic forms of rodent malaria parasites at the site of inoculation: clearance after immunization, susceptibility to primaquine, and contribution to blood-stage infection[J]. Infect Immun, 2012, 80(6): 2158-2164. |
| [16] | Risco-Castillo V, Top?u S, Marinach C, et al. Malaria sporozoites traverse host cells within transient vacuoles[J]. Cell Host Microbe, 2015, 18(5): 593-603. |
| [17] | Pradel G, Frevert U. Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion[J]. Hepatology, 2001, 33(5): 1154-1165. |
| [18] | Mota MM, Hafalla JC, Rodriguez A. Migration through host cells activates Plasmodium sporozoites for infection[J]. Nat Med, 2002, 8(11): 1318-1322. |
| [19] | Carrolo M, Giordano S, Cabrita-Santos L, et al. Hepatocyte growth factor and its receptor are required for malaria infection[J]. Nat Med, 2003, 9(11): 1363-1369. |
| [20] | Frevert U, Engelmann S, Zougbédé S, et al. Intravital observation of Plasmodium berghei sporozoite infection of the liver[J]. PLoS Biol, 2005, 3(6): e192. |
| [21] | Pradel G, Garapaty S, Frevert U. Proteoglycans mediate malaria sporozoite targeting to the liver[J]. Mol Microbiol, 2002, 45(3): 637-651. |
| [22] | Sturm A, Graewe S, Franke-Fayard B, et al. Alteration of the parasite plasma membrane and the parasitophorous vacuole membrane during exo-erythrocytic development of malaria parasites[J]. Protist, 2009, 160(1): 51-63. |
| [23] | Rodrigues CD, Hannus M, Prudêncio M, et al. Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection[J]. Cell Host Microbe, 2008, 4(3): 271-282. |
| [24] | Yalaoui S, Zougbédé S, Charrin S, et al. Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain[J]. PLoS Pathog, 2008, 4(2): e1000010. |
| [25] | Silvie O, Greco C, Franetich JF, et al. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species[J]. Cell Microbiol, 2006, 8(7): 1134-1146. |
| [26] | Kiyuka PK, Meri S, Khattab A. Complement in malaria: Immune evasion strategies and role in protective immunity[J]. FEBS Lett, 2020, 594(16): 2502-2517. |
| [27] | Simon N, Lasonder E, Scheuermayer M, et al. Malaria parasites co-opt human factor H to prevent complement-mediated lysis in the mosquito midgut[J]. Cell Host Microbe, 2013, 13(1): 29-41. |
| [28] | Kennedy AT, Schmidt CQ, Thompson JK, et al. Recruitment of factor H as a novel complement evasion strategy for blood-stage Plasmodium falciparum infection[J]. J Immunol, 2016, 196(3): 1239-1248. |
| [29] | Kennedy AT, Wijeyewickrema LC, Huglo A, et al. Recruitment of human C1 esterase inhibitor controls complement activation on blood stage Plasmodium falciparum merozoites[J]. J Immunol, 2017, 198(12): 4728-4737. |
| [30] | Kurtovic L, Behet MC, Feng GQ, et al. Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children[J]. BMC Med, 2018, 16(1): 61. |
| [31] | Boyle MJ, Reiling L, Feng GQ, et al. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria[J]. Immunity, 2015, 42(3): 580-590. |
| [32] | Reiling L, Boyle MJ, White MT, et al. Targets of complement-fixing antibodies in protective immunity against malaria in children[J]. Nat Commun, 2019, 10(1): 610. |
| [33] | Behet MC, Kurtovic L, van Gemert GJ, et al. The complement system contributes to functional antibody-mediated responses induced by immunization with Plasmodium falciparum malaria sporozoites[J]. Infect Immun, 2018, 86(7): e00920-e00917. |
| [34] | Arbore G, Kemper C, Kolev M. Intracellular complement—the complosome—in immune cell regulation[J]. Mol Immunol, 2017, 89: 2-9. |
| [35] | Kolev M le Friec G, Kemper C. Complement: tapping into new sites and effector systems[J]. Nat Rev Immunol, 2014, 14(12): 811-820. |
| [36] | Liszewski MK, Kolev M le Friec G, et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation[J]. Immunity, 2013, 39(6): 1143-1157. |
| [37] | Tam JC, Bidgood SR, McEwan WA, et al. Intracellular sensing of complement C3 activates cell autonomous immunity[J]. Science, 2014, 345(6201): 1256070. |
| [38] | Khan ZM, Vanderberg JP. Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and Plasmodium yoelii sporozoites[J]. Infect Immun, 1991, 59(8): 2529-2534. |
| [39] | Silvie O, Rubinstein E, Franetich JF, et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity[J]. Nat Med, 2003, 9(1): 93-96. |
| [40] | Lalli PN, Strainic MG, Yang M, et al. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis[J]. Blood, 2008, 112(5): 1759-1766. |
| [41] | Zenklusen I, Jongo S, Abdulla S, et al. Immunization of malaria-preexposed volunteers with PfSPZ vaccine elicits long-lived IgM invasion-inhibitory and complement-fixing antibodies[J]. J Infect Dis, 2018, 217(10): 1569-1578. |
| [42] | Kawamoto Y, Winger LA, Hong K, et al. Plasmodium berghei: Sporozoites are sensitive to human serum but not susceptible host serum[J]. Exp Parasitol, 1992, 75(3): 361-368. |
| [43] | Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation pathway[J]. Nat Med, 2006, 12(6): 682-687. |
| [44] | Ramos TN, Darley MM, Weckbach S, et al. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria[J]. J Biol Chem, 2012, 287(29): 24734-24738. |
| [45] | Ernest M, Rosa TFA, Pala ZR, et al. Plasmodium falciparum gametes and sporozoites hijack plasmin and factor H to evade host complement killing[J]. Microbiol Spectr, 2023, 11(3): e0449322. |
| [46] | Schmidt CQ, Kennedy AT, Tham WH. More than just immune evasion: hijacking complement by Plasmodium falciparum[J]. Mol Immunol, 2015, 67(1): 71-84. |
| [47] | Atkinson JP, Glew RH, Neva FA, et al. Serum complement and immunity in experimental simian malaria. Ⅱ. Preferential activation of early components and failure of depletion of late components to inhibit protective immunity[J]. J Infect Dis, 131(1): 26-33. |
| [48] | Ramos TN, Bullard DC, Barnum SR. Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria[J]. Parasite Immunol, 2012, 34(11): 547-550. |
/
| 〈 |
|
〉 |